Construction and immunogenicity of pseudotype baculovirus expressing Toxoplasma gondii SAG1 protein in BALB/c mice model

Vaccine

Volumn 28, Issue 7, 2010, Pages 1803-1807

  Fang, Rui ^a   Feng, Hanli ^b   Nie, Hao ^a   Wang, Lixia ^a   Tu, Pan ^a   Song, Qiqi ^a   Zhou, Yanqin ^a   Zhao, Junlong ^a  

^a HUAZHONG AGRICULTURAL UNIVERSITY   (China)

^b Hubei Entry Exit Inspection and Quarantine Bureau   (China)

Author keywords

Immunogenicity; Pseudotype baculovirus; Toxoplasma gondii SAG1

Indexed keywords

DNA VACCINE; ENHANCED GREEN FLUORESCENT PROTEIN; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 4; PROTEIN G; PROTEIN SAG1; RECOMBINANT PROTEIN; TOXOPLASMA GONDII VACCINE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; IMMUNIZATION; IMMUNOFLUORESCENCE TEST; IMMUNOGENICITY; KIDNEY CELL; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION; SURVIVAL RATE; TACHYZOITE; TOXOPLASMA GONDII; TOXOPLASMOSIS;

ANIMALS; ANTIBODIES, PROTOZOAN; ANTIGENS, PROTOZOAN; BACULOVIRIDAE; CELL LINE; CELL PROLIFERATION; FEMALE; INTERFERON-GAMMA; INTERLEUKIN-10; INTERLEUKIN-4; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED BALB C; PROTOZOAN PROTEINS; PROTOZOAN VACCINES; SPLEEN; SWINE; TOXOPLASMA; TOXOPLASMOSIS, ANIMAL; VACCINES, DNA;

EID: 75249107940     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2009.12.005     Document Type: Article

References (33)

1. Tenter A.M., Heckeroth A.R., and Weiss L.M. Toxoplasma gondii: from animals to humans. Int J Parasitol 30 12-13 (2000) 1217-1258
2. Montoya J.G., and Liesenfeld O. Toxoplasmosis. Lancet 363 9425 (2004) 1965-1976
3. Kim K., and Weiss L.M. Toxoplasma: the next 100 years. Microb Infect 10 9 (2008) 978-984
4. Kasper L.H., and Buzoni-Gatel D. Some opportunistic parasitic infections in AIDS: Candidiasis, Pneumocystosis, Cryptosporidiosis, Toxoplasmosis. Parasitol Today 14 4 (1998) 150-156
5. Liu Q., Gao S., Jiang L., Shang L., Men J., Wang Z., et al. A recombinant pseudorabies virus expressing TgSAG1 protects against challenge with the virulent Toxoplasma gondii RH strain and pseudorabies in BALB/c mice. Microb Infect 10 12-13 (2008) 1355-1362
6. Bhopale G.M. Development of a vaccine for toxoplasmosis: current status. Microb Infect 5 5 (2003) 457-462
7. Innes E.A., and Vermeulen A.N. Vaccination as a control strategy against the coccidial parasites Eimeria, Toxoplasma and Neospora. Parasitology 133 Suppl. (2006) S145-S168
8. Darcy F., Maes P., Gras-Masse H., Auriault C., Bossus M., Deslee D., et al. Protection of mice and nude rats against toxoplasmosis by a multiple antigenic peptide construction derived from Toxoplasma gondii P30 antigen. J Immunol 149 11 (1992) 3636-3641
9. Wang H., Liu Q., Liu K., Zhong W., Gao S., Jiang L., et al. Immune response induced by recombinant Mycobacterium bovis BCG expressing ROP2 gene of Toxoplasma gondii. Parasitol Int 56 4 (2007) 263-268
10. Mateus-Pinilla N.E., Dubey J.P., Choromanski L., and Weigel R.M. A field trial of the effectiveness of a feline Toxoplasma gondii vaccine in reducing T. gondii exposure for swine. J Parasitol 85 5 (1999) 855-860
11. Boyce F.M., and Bucher N.L. Baculovirus-mediated gene transfer into mammalian cells. Proc Natl Acad Sci USA 93 6 (1996) 2348-2352
12. Hofmann C., Sandig V., Jennings G., Rudolph M., Schlag P., and Strauss M. Efficient gene transfer into human hepatocytes by baculovirus vectors. Proc Natl Acad Sci USA 92 22 (1995) 10099-10103
13. Shoji I., Aizaki H., Tani H., Ishii K., Chiba T., Saito I., et al. Efficient gene transfer into various mammalian cells, including non-hepatic cells, by baculovirus vectors. J Gen Virol 78 Pt 10 (1997) 2657-2664
14. Hu Y.C. Baculovirus as a highly efficient expression vector in insect and mammalian cells. Acta Pharmacol Sin 26 (2005) 405-416
15. Ghosh S., Parvez M.K., Banerjee K., Sarin S.K., and Hasnain S.E. Baculovirus as mammalian cell expression vector for gene therapy: an emerging strategy. Mol Ther 6 1 (2002) 5-11
16. Kost T.A., Condreay J.P., and Jarvis D.L. Baculovirus as versatile vectors for protein expression in insect and mammalian cells. Nat Biotechnol 23 (2005) 567-575
17. Barsoum J., Brown R., McKee M., and Boyce F.M. Efficient transduction of mammalian cells by a recombinant baculovirus having the vesicular stomatitis virus G glycoprotein. Hum Gene Ther 8 17 (1997) 2011-2018
18. Abe T., Takahashi H., Hamazaki H., Miyano-Kurosaki N., Matsuura Y., and Takaku H. Baculovirus induces an innate immune response and confers protection from lethal influenza virus infection in mice. J Immunol 171 3 (2003) 1133-1139
19. Wang S., Fang L., Fan H., Jiang Y., Pan Y., Luo R., et al. Construction and immunogenicity of pseudotype baculovirus expressing GP5 and M protein of porcine reproductive and respiratory syndrome virus. Vaccine 25 49 (2007) 8220-8227
20. Li Y., Ye J., Cao S., Xiao S., Zhao Q., Liu X., et al. Immunization with pseudotype baculovirus expressing envelope protein of Japanese encephalitis virus elicits protective immunity in mice. J Gene Med 11 1 (2009) 57-65
21. Fan H., Pan Y., Fang L., Wang D., Wang S., Jiang Y., et al. Construction and immunogenicity of recombinant pseudotype baculovirus expressing the capsid protein of porcine circovirus type 2 in mice. J Virol Methods 150 1-2 (2008) 21-26
22. Strauss R., Huser A., Ni S., Tuve S., Kiviat N., Sow P.S., et al. Baculovirus-based vaccination vectors allow for efficient induction of immune responses against Plasmodium falciparum circumsporozoite protein. Mol Ther 15 1 (2007) 193-202
23. Caetano B.C., Bruna-Romero O., Fux B., Mendes E.A., Penido M.L., and Gazzinelli R.T. Vaccination with replication-deficient recombinant adenoviruses encoding the main surface antigens of Toxoplasma gondii induces immune response and protection against infection in mice. Hum Gene Ther 17 4 (2006) 415-426
24. Fachado A., Rodriguez A., Angel S.O., Pinto D.C., Vila I., Acosta A., et al. Protective effect of a naked DNA vaccine cocktail against lethal toxoplasmosis in mice. Vaccine 21 13-14 (2003) 1327-1335
25. Yang C.D., Chang G.N., and Chao D. Protective immunity against Toxoplasma gondii in mice induced by a chimeric protein rSAG1/2. Parasitol Res 92 1 (2004) 58-64
26. Zhang J., He S., Jiang H., Yang T., Cong H., Zhou H., et al. Evaluation of the immune response induced by multiantigenic DNA vaccine encoding SAG1 and ROP2 of Toxoplasma gondii and the adjuvant properties of murine interleukin-12 plasmid in BALB/c mice. Parasitol Res 101 2 (2007) 331-338
27. Diab M.R., and El-Bahy M.M. Toxoplasma gondii: virulence of tachyzoites in serum free media at different temperatures. Exp Parasitol 118 1 (2008) 75-79
28. Facciabene A., Aurisicchio L., and La Monica N. Baculovirus vectors elicit antigen-specific immune responses in mice. J Virol 78 16 (2004) 8663-8672
29. Dubey J.P., and Thulliez P. Persistence of tissue cysts in edible tissues of cattle fed Toxoplasma gondii oocysts. Am J Vet Res 54 2 (1993) 270-273
30. Pieroni L., Maione D., and La Monica N. In vivo gene transfer in mouse skeletal muscle mediated by baculovirus vectors. Hum Gene Ther 12 8 (2001) 871-881
31. Pieroni L.M.D., and La Monica N. In vivo gene transfer in mouse skeletal muscle mediated by baculovirus vectors. Hum Gene Ther 12 (2001) 871-881
32. Gronowski A.M., Hilbert D.M., Sheehan K.C., Garotta G., and Schreiber R.D. Baculovirus stimulates antiviral effects in mammalian cells. J Virol 73 12 (1999) 9944-9951
33. Hervas-Stubbs S., Rueda P., Lopez L., and Leclerc C. Insect baculoviruses strongly potentiate adaptive immune responses by inducing type I IFN. J Immunol 178 4 (2007) 2361-2369